Medical News

RSS

Company reaches $28 million settlement for Medicare program

The Tennesseean: "Healthways Inc. will return $28 million to Medicare's overseer under a settlement related to the company's participation in a pilot program to determine the effectiveness of its nurse-based health coaching for chronically ill seniors." The Centers for Medicare and Medicaid Services had paid the company $72 million for the pilot program, which ended two years ago, under the condition that it meet "specific targets for cost savings, health outcomes and patient satisfaction."

7 Dec 2010

New sensitive blood test could determine unrecognized heart disease

A more sensitive version of a blood test typically used to confirm that someone is having a heart attack could indicate whether a seemingly healthy, middle-aged person has unrecognized heart disease and an increased risk of dying, UT Southwestern Medical Center researchers have found.

7 Dec 2010

Deal for year-long doc fix in the works

Politico: Senators reached a tentative deal Monday that would tap health law funds to avert a scheduled pay cut for physicians. The deal would take back about $19.2 billion in health law subsidies to help people buy health insurance beginning in 2014. It "would change how much money consumers would have to repay if their income status changes mid-year, pushing them out of the eligibility bracket.

7 Dec 2010

eLINCx to implement GE's eHealth Information Exchange across Wooster, Dunlap Community Hospitals

eLINCx, founded earlier this year to provide quality healthcare services to central Ohio communities, and GE Healthcare announced today that eLINCx will implement GE Healthcare's eHealth Information Exchange across Wooster Community Hospital, Dunlap Community Hospital and more than a dozen physician practices.

7 Dec 2010

Early group daycare exposure protects kids from infections later: Study

A new study reassures parents that although young kids might get sick more often when they first start group childcare, these same kids get fewer infections later in their childhood. About one in three U.S. kids receives organized childcare before reaching kindergarten age, whether at a daycare center or a school.

7 Dec 2010

Psychotic depression: the reason for treatment failure with antidepressants

A new study shows that patients with depression who also have psychotic-like symptoms, feelings of being persecuted, or believing others are plotting against them or hearing voices are less likely to respond to antidepressants. The study also showed that bipolar disorder does not appear to be associated with treatment resistance in patients with depression as believed earlier.

7 Dec 2010

Contrave, new weight loss pill gets FDA panel nod

A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics’ weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave’s approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel’s recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.

7 Dec 2010

Humble aspirin reduces cancer death rates

A new study has shown aspirin cuts down the death rates from a range of cancers. The study reviewed data from eight previous trials involving more than 25,000 patients found that those who took just 75mg of aspirin a day (one-eighth of a normal dose) could reduce their death rates from cancer by 21% with benefits continuing long after patients stopped taking the pill.

7 Dec 2010

Mobile phones use during pregnancy linked to behavioural problems in kids: Study

A new study finds that pregnant mums who regularly use mobile phones may be more likely to have children with behavioral problems, especially if these kids themselves start using mobile phones in their first seven years.

7 Dec 2010

Cognitively-impaired human research subjects need better protection

Practices for protecting human research subjects with Alzheimer’s disease and other conditions that make them incapable of giving informed consent are widely variable and in need of more concrete ethical and legal guidance, according to a study in IRB: Ethics & Human Research.

7 Dec 2010

Size exclusion chromatography illuminates protein crystallization

Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins.

From Malvern Panalytical 7 Dec 2010

Injury prevention for young volleyball athletes

When volleyball was invented 115 years ago in Holyoke, Mass., it was meant to be less rough than basketball, another emerging indoor sport that started four years earlier at a nearby YMCA.

7 Dec 2010

Sheathless transradial intervention highly successful in treating complex lesions

Cardiologists from the Mayo Clinic performed sheathless transradial percutaneous coronary intervention (PCI) to remedy complex lesions, achieving a 90% success rate with no radial complications. Standard guiding catheters were used during the procedure. Details of this novel approach—overcoming the last hurdle to greater adoption of transradial PCI in the U.S.—are published in the December issue of Catheterization and Cardiovascular Intervention, the official journal of The Society for Cardiovascular Angiography and Interventions.

7 Dec 2010

European summit agrees that lifestyle change is the only answer to heart disease

‘Some progress, but the big challenges remain’. This was the verdict after the European Society of Cardiology (ESC) hosted the 2010 European Summit on CVD Prevention on 30 November. The summit was attended by a broad cross-section of medical experts, healthcare organisations, national societies, regulators and representatives from the European Union (EU).

7 Dec 2010

Miracle Applications to sell and market Bioflex Medical Magnetic products

Miracle Applications Corp. is proud to announce it has entered into a Licensing Agreement with Bioflex Medical Magnetic Inc. to sell and market select Bioflex products. The Bioflex magnet is clinically proven to reduce pain, accelerate healing and improve circulation. Bioflex Medical Magnetic Inc. was formed in October, 1986 and BIOflex® Concentric Circle Magnet is the original magnet for human use.

7 Dec 2010

Fluxion Biosciences announces launch of new BioFlux 1000Z system for live cell imaging

Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.

From Fluxion Biosciences 7 Dec 2010

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Orthovita, Inc. , an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities. Orthovita expects to launch the newest addition to its bone graft substitute product line by late February or early March of 2011.

7 Dec 2010

Aetna announces agreement to acquire Medicity

Aetna today announced that it has entered into an agreement to acquire Medicity, a health information exchange technology company, headquartered in Salt Lake City, Utah.

7 Dec 2010

MP receives FDA IND approval for clinical trial with HTLV-I/II ELISA 4.0 and HTLV Blot.2.4

MP Biomedicals LLC announced today that it has received approval of its investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) to start pivotal clinical trials in the USA with the MP Diagnostics™ HTLV-I/II ELISA 4.0 and HTLV Blot.2.4. Studies will be conducted within the American Red Cross, the California Department of Public Health, and LABS, Inc. The company is working closely with the principal investigator of the American Red Cross sites, Dr. Susan Stramer, Executive Scientific Officer.

From MP Biomedicals, LLC 7 Dec 2010

IASIS Healthcare fourth quarter net revenue increases 1.6% to $629.9 million

IASIS Healthcare LLC today announced financial and operating results for the fiscal fourth quarter and year ended September 30, 2010.

7 Dec 2010

Medical News

Company reaches $28 million settlement for Medicare program

New sensitive blood test could determine unrecognized heart disease

Deal for year-long doc fix in the works

eLINCx to implement GE's eHealth Information Exchange across Wooster, Dunlap Community Hospitals

Early group daycare exposure protects kids from infections later: Study

Psychotic depression: the reason for treatment failure with antidepressants

Contrave, new weight loss pill gets FDA panel nod

Humble aspirin reduces cancer death rates

Mobile phones use during pregnancy linked to behavioural problems in kids: Study

Cognitively-impaired human research subjects need better protection

Size exclusion chromatography illuminates protein crystallization

Injury prevention for young volleyball athletes

Sheathless transradial intervention highly successful in treating complex lesions

European summit agrees that lifestyle change is the only answer to heart disease

Miracle Applications to sell and market Bioflex Medical Magnetic products

Fluxion Biosciences announces launch of new BioFlux 1000Z system for live cell imaging

Orthovita granted FDA marketing clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Aetna announces agreement to acquire Medicity

MP receives FDA IND approval for clinical trial with HTLV-I/II ELISA 4.0 and HTLV Blot.2.4

IASIS Healthcare fourth quarter net revenue increases 1.6% to $629.9 million

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News